MYB expression is essential for the initiation and maintenance of MLL-fusion induced AML, and indeed these leukaemias are particularly sensitive to MYB inhibition when compared to normal haematopoietic cells and leukaemias induced by several other oncogenes11–13. This evidence concerns the gene KMT2A and leukemia.